Lista de obras - Lars Bastholt - Dominio Público Uruguay

A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients ⬇️

artículo científico publicado el 1 de enero de 1991

A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma.

artículo científico publicado en 2002

A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response

artículo científico publicado en 2008

A phase II study of thalidomide in patients with brain metastases from malignant melanoma.

artículo científico publicado en 2008

A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer.

artículo científico publicado en 2007

A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma

artículo científico publicado en 2005

A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma

artículo científico publicado en 2000

A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer

artículo científico publicado en 2013

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.

artículo científico publicado en 2011

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

artículo científico publicado en 1998

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries

artículo científico publicado en 2018

Accidental visualization of mesenteric lymph nodes by bipedal lymphography

scientific article published on 01 March 1983

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group

scientific article published on 01 October 1987

Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma

artículo científico publicado en 2019

Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma ⬇️

artículo científico publicado el 1 de febrero de 2013

Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon

artículo científico publicado en 2009

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels

artículo científico publicado en 2014

Cancer of the larynx--treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients

artículo científico publicado en 2002

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

artículo científico publicado en 2015

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

scientific article published on 01 May 2000

Consumption of the epidermis: a suggested precursor of ulceration associated with increased proliferation of melanoma cells

artículo científico publicado en 2015

Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form.

artículo científico publicado en 2018

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab.

artículo científico publicado en 2018

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

artículo científico

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines

scientific article published on 06 July 2019

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

artículo científico publicado en 2015

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

artículo científico publicado en 2016

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

artículo científico publicado en 2019

Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging

artículo científico publicado en 2002

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

artículo científico publicado en 1996

Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients

artículo científico publicado en 2005

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.

scientific article published on 10 September 2016

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

artículo científico publicado en 2020

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

artículo científico publicado en 2005

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

artículo científico publicado en 2023

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019

scientific article published on 09 January 2020

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019

scientific article published on 19 December 2019

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial

artículo científico publicado en 2015

Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma.

artículo científico publicado en 2014

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

artículo científico publicado en 2003

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

artículo científico publicado en 2019

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

artículo científico publicado en 2011

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

artículo científico publicado en 2019

High-dose platinum chemotherapy in advanced ovarian cancer: a phase II study

scientific article published on 01 January 1992

How to improve cytotoxic therapy in advanced breast cancer.

artículo científico publicado en 1990

Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery

artículo científico publicado en 2002

Immune checkpoint inhibitors and endocrinological side effects ⬇️

artículo científico publicado en 2017

Immunotherapy is cancer treatment with a novel side-effect profile ⬇️

artículo científico publicado en 2017

Immunotherapy of distant metastatic disease.

scientific article published on August 2009

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation

scientific article published on 01 April 1997

Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma

scientific article published on 11 September 2020

Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial

artículo científico publicado en 2007

Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer

scientific article published on 01 January 1994

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

artículo científico publicado en 2017

Large discrepancy in the results of sensitive measurements of thyroglobulin antibodies in the follow-up on thyroid cancer: a diagnostic dilemma.

artículo científico publicado en 2012

Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration.

artículo científico publicado en 2017

Lymph node metastases from laryngeal and pharyngeal carcinomas--calculation of burden of metastasis and its impact on prognosis

artículo científico publicado en 1998

Measured and genetically predicted plasma YKL-40 levels and melanoma mortality

scientific article published on 01 November 2019

MelanA-negative spindle-cell associated melanoma, a distinct inflammatory phenotype correlated with dense infiltration of CD163 macrophages and loss of E-cadherin

artículo científico publicado en 2015

Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries

artículo científico publicado en 2015

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments

artículo científico publicado en 2017

Motesanib diphosphate in progressive differentiated thyroid cancer.

artículo científico publicado en 2008

Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer

artículo científico

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients

artículo científico publicado en 2005

Osseointegrated implants for prosthetic rehabilitation after treatment of cancer of the oral cavity

artículo científico publicado en 1997

Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation

artículo científico publicado en 2000

PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy

scientific article published on 31 January 2017

Papillary microcarcinoma of the thyroid gland: Is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?

artículo científico publicado en 2008

Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence.

artículo científico publicado en 2012

Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.

artículo científico publicado en 2013

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences

scientific article published on 09 April 2020

Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites.

artículo científico publicado en 2018

Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck

artículo científico publicado en 2007

Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients

artículo científico publicado en 1987

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

artículo científico publicado en 2009

Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma

artículo científico publicado en 2011

Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter

artículo científico publicado en 2012

Prognostic Factors in Papillary and Follicular Thyroid Carcinomas

artículo científico publicado en 1998

Prognostic and predictive value of YKL-40 in stage IIB-III melanoma

artículo científico publicado en 2016

Prognostic stratification of ulcerated melanoma: not only the extent matters

artículo científico publicado en 2014

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

artículo científico publicado en 2016

Pulmonary airflow obstruction following lymphography

scientific article published on 01 January 1982

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

artículo científico publicado en 2019

Recall radiation myelitis after stereotactic radiation and dabrafenib in metastatic melanoma.

artículo científico publicado en 2016

Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration

scientific article published on 29 July 2008

Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy

artículo científico publicado en 2010

Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma ⬇️

artículo científico publicado el 28 de abril de 2013

Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA.

artículo científico publicado en 2003

Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy

artículo científico publicado en 2019

Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma

artículo científico publicado en 2012

Small molecules and targeted therapies in distant metastatic disease.

scientific article published on August 2009

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2014

Stabilization of circulating thyroglobulin mRNA transcripts in patients treated for differentiated thyroid carcinoma.

artículo científico publicado en 2016

Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study

scientific article published on 01 February 2000

Surgery and radiotherapy in the treatment of cutaneous melanoma

artículo científico publicado en 2009

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

artículo científico publicado en 2020

The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer

artículo científico publicado en 1994

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.

artículo científico publicado en 2018

The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.

artículo científico publicado en 2017

The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanoma

scientific article published on 01 October 2007

The real-world impact of modern treatments on the survival of patients with metastatic melanoma

scientific article published on 31 December 2018

The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous

scientific article published on 03 September 2019

The role of FDG-PET/CT in preoperative staging of sentinel lymph node biopsy-positive melanoma patients.

artículo científico publicado en 2016

Total Thyroidectomy for Thyroid Cancer Followed by Thyroid Storm due to Thyrotropin Receptor Antibody Stimulation of Metastatic Thyroid Tissue

artículo científico publicado en 2017

Treatment of BRAF-mutated metastatic melanoma ⬇️

artículo científico publicado en 2016

Trends in melanoma in the elderly in Denmark, 1980-2012.

artículo científico publicado en 2016

Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial

artículo científico publicado en 2011

Weekly oral idarubicin in advanced prostatic cancer. A phase II study

artículo científico publicado en 1992

[The possible mutagenic effects of cytostatics on nurses in an oncology department]

scientific article published on 01 August 1984

Lista de obras de Lars Bastholt

A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients ⬇️

A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma.

A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response

A phase II study of thalidomide in patients with brain metastases from malignant melanoma.

A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer.

A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma

A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma

A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries

Accidental visualization of mesenteric lymph nodes by bipedal lymphography

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group

Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma

Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma ⬇️

Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels

Cancer of the larynx--treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

Consumption of the epidermis: a suggested precursor of ulceration associated with increased proliferation of melanoma cells

Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form.

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab.

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial

Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma.

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

High-dose platinum chemotherapy in advanced ovarian cancer: a phase II study

How to improve cytotoxic therapy in advanced breast cancer.

Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery

Immune checkpoint inhibitors and endocrinological side effects ⬇️

Immunotherapy is cancer treatment with a novel side-effect profile ⬇️

Immunotherapy of distant metastatic disease.

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation

Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma

Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial

Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

Large discrepancy in the results of sensitive measurements of thyroglobulin antibodies in the follow-up on thyroid cancer: a diagnostic dilemma.

Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration.

Lymph node metastases from laryngeal and pharyngeal carcinomas--calculation of burden of metastasis and its impact on prognosis

Measured and genetically predicted plasma YKL-40 levels and melanoma mortality

MelanA-negative spindle-cell associated melanoma, a distinct inflammatory phenotype correlated with dense infiltration of CD163 macrophages and loss of E-cadherin

Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments

Motesanib diphosphate in progressive differentiated thyroid cancer.

Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients

Osseointegrated implants for prosthetic rehabilitation after treatment of cancer of the oral cavity

Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation

PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy

Papillary microcarcinoma of the thyroid gland: Is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?

Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence.

Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences

Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites.

Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck

Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma

Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter

Prognostic Factors in Papillary and Follicular Thyroid Carcinomas

Prognostic and predictive value of YKL-40 in stage IIB-III melanoma